Founder and CEO of Cambridge-based TidalSense, a respiratory technology company developing a handheld COPD diagnostic device using CO2 sensing and machine learning. Personally motivated by her own delayed asthma diagnosis and near-fatal attacks in her 20s.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Crossborder Impact Ventures led TidalSense's $19M round, sharing the company's ambition to scale globally and address the diagnostic gap in low- and middle-income countries where COPD testing access is near zero.
CEO Ameera Patel describes a handheld COPD diagnostic device using CO2 sensing and ML interpretation that delivers results in under 4 minutes vs 1 hour for spirometry, with regulatory clearance, NHS deployment, and inbound demand from 60+ countries.
TidalSense has developed a handheld CO2-sensor device with machine learning interpretation that diagnoses COPD in under 4 minutes versus 1 hour for legacy spirometry, with NHS deployment showing overwhelming demand and plans for FDA clearance and China market entry.